Why the study?
Does reperfusion therapy with low-dose insulin or IGF2 reduce infarct size and improve functional recovery in a porcine model of ischaemia and reperfusion?
Does reperfusion therapy with low-dose insulin or IGF2 reduce infarct size and improve functional recovery in a porcine model of ischaemia and reperfusion?
Reperfusion therapy with low-dose insulin or IGF2 did not reduce infarct size or improve myocardial function in a porcine model of ischaemia-reperfusion.
No takes yet. Share an insight, caveat, or question.
No infarct size benefit with low-dose insulin or IGF2 in porcine ischaemia-reperfusion; leaves open translation to clinical reperfusion strategies.
Salminen et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: